[Treatment of pelvic endometriosis with danazol. Effects on carbohydrate metabolism].
D000328:Adult; D002096:C-Peptide / Q000378:metabolism; D050260:Carbohydrate Metabolism; D003613:Danazol / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004715:Endometriosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006946:Hyperinsulinism / Q000139:chemically induced; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D008134:Long-Term Care; D011245:Pregnadienes / Q000627:therapeutic use*; D011446:Prospective Studies
D002096:C-Peptide; D007328:Insulin; D011245:Pregnadienes; D003613:Danazol
Traitement de l'endométriose pelvienne par le danazol. Incidence sur le métabolisme glucidique.